Phil Market Share Analysis for August 2026

PHIL streamlines the prescription access journey for pharma brands, improving patient access, affordability, adherence, and commercial success.

Health > Pharmacy

Domainphil.us

Year Founded2015

Employees51 - 200

Annual Revenue$10M - $15M

Phil

Phil (including company regionals)

phil.us

See more website traffic and engagement information

Phil Revenue up to August 2026 is 10M - 15M

revenue generated by Phil top domains

Phil top domains revenue over 3 years

Revenue for Phil top domains

phil.us10M - 15M

See more with Sales Intelligence

Total visits to Phil's top domains

Understand Phil market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

phil.us355.8K

See more with Sales Intelligence

Avg. visit duration in Phil's top domains

Analyze Phil engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

phil.us00:01:28

See more with Sales Intelligence

Avg. pageviews on Phil's top domains

See how Phil keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

phil.us2.60

See more with Sales Intelligence

Phil top competitors by domain

Top similar sites in August 2026, ranked by their affinity

cencora.comCompany NameCencora, Inc.Employees> 10001HQUnited States, Pennsylvania, ConshohockenAnnual revenue> $1BTotal visits529.3KJobs and Career > Jobs and Career - Other

Top technologies used by Phil

These are the website technologies, by industry, used by Phil top domains

Advertising (17)

Google Adsense

Conversion & Analytics (9)

Google Analytics

Marketing (3)

Google Marketing Platform

Mobile (3)

Meta Viewport

More Technologies

12

See all

News & Signals from Phil

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPhil Inc. launches DTP program.Tenpoint and PHIL have partnered to launch an innovative DTP program, delivering YUVEZZI(TM) directly to patients through a seamless access experience with affordable, transparent pricing, home delivery, and dedicated support.

NewsK2 HealthVentures invests into Phil Inc. $60M in growth debt financing.Phil, a leading software-driven pharmaceutical commercialization platform, announced a $60 million growth debt financing from K2 HealthVentures, a healthcare and life sciences-focused investment firm.

NewsPhil Inc. attends event The Festival Sale.At The Festival Sale, Thefestivalsale often see how figures like Phil inspire a dedicated following, and his story certainly captivates.